GreenLight laser for prostates over 100 ml: What is the evidence?

Current Opinion in Urology

Volumn 26, Issue 1, 2015, Pages 28-34

  Stone, Benjamin V ^a   Chughtai, Bilal ^a   Kaplan, Steven A ^a   Te, Alexis E ^a   Lee, Richard K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

benign prostatic hyperplasia; laser therapy; organ size; photoselective vaporization of the prostate; prostate

Indexed keywords

CAUTERIZATION; COST BENEFIT ANALYSIS; GREENLIGHT LASER; HOSPITALIZATION; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOW LEVEL LASER THERAPY; OPERATION DURATION; PERIOPERATIVE PERIOD; PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE; POSTOPERATIVE COMPLICATION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SIZE; PROSTATE SURGERY; RETREATMENT; REVIEW; TRANSURETHRAL RESECTION; URINE FLOW RATE; UROLOGICAL LASER SYSTEM; CATHETERIZATION; HEMOSTASIS; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PROSTATE FLUID; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADVERSE EFFECTS; DEVICES; EQUIPMENT DESIGN; LASER; MALE; ORGAN SIZE; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSTATE; PROSTATIC HYPERPLASIA; RISK FACTOR; TREATMENT OUTCOME; VOLATILIZATION;

EQUIPMENT DESIGN; HUMANS; LASER THERAPY; LASERS; MALE; ORGAN SIZE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSTATE; PROSTATIC HYPERPLASIA; RETREATMENT; RISK FACTORS; TREATMENT OUTCOME; VOLATILIZATION;

EID: 84952327438     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0000000000000237     Document Type: Review

References (29)

1. Gilling PJ, Kennett KM, Fraundorfer MR. Holmium laser enucleation of the prostate for glands larger than 100 g: An endourologic alternative to open prostatectomy. J Endourol 2000; 14:529-531.
2. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 2008; 53:160-166.
3. Ahyai SA, Gilling P, Kaplan SA, et al. Meta-Analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010; 58:384-397.
4. Placer J, Gelabert-Mas A, Vallmanya F, et al. Holmium laser enucleation of prostate: outcome and complications of self-Taught learning curve. Urology 2009; 73:1042-1048.
5. Woo HH. Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (120 cc). BJU Int 2011; 108:860-863.
6. Woo H, Reich O, Bachmann A, et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: Those in retention, on anticoagulants, and with large prostates ( 80 ml). Eur Urol Suppl 2008; 7:378-383.
7. Alivizatos G, Skolarikos A, Chalikopoulos D, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol 2008; 54:427-437.
8. Ruszat R, Wyler S, Seifert HH, et al. Photoselective vaporization of the prostate: experience with prostate adenomas >80 cm3. Urologe A 2006; 45:858-864.
9. Rajbabu K, Chandrasekara SK, Barber NJ, et al. Photoselective vaporization of the prostate with the potassium-Titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 2007; 100:593-598.
10. Gu X, Vricella GJ, Spaliviero M, Wong C. Does size really matter? The impact of prostate volume on the efficacy and safety of GreenLight HPS laser photoselective vaporization of the prostate. J Endourol 2012; 26:525-530.
11. Tasci AI, Ilbey YO, Luleci H, et al. 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology 2011; 78:134-140.
12. Ruszat R, Seitz M, Wyler SF, et al. GreenLight laser vaporization of the prostate: single-center experience and long-Term results after 500 procedures. Eur Urol 2008; 54:893-901.
13. Horasanli K, Silay MS, Altay B, et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: A short-Term prospective randomized trial. Urology 2008; 71:247-251.
14. Elmansy H, Baazeem A, Kotb A, et al. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. J Urol 2012; 188:216-221.
15. Bachmann A, Muir GH, Collins EJ, et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 2012; 61:600-607.
16. Ben-Zvi T, Hueber PA, Liberman D, et al. GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: A prospective comparative analysis after 200 cases in a single-center study. Urology 2013; 81:853-858.
17. Bachmann A, Tubaro A, Barber N, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial: The GOLIATH study. Eur Urol 2014; 65:931-942.
18. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 2015; 193:570-578.
19. Teng J, Zhang D, Li Y, et al. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: A systematic review and meta-Analysis. BJU Int 2013; 111:312-323.
20. Hueber PA, Bienz MN, Valdivieso R, et al. Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 2015; 194:462-469.
21. Altay B, Erkurt B, Kiremit MC, et al. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 2015; 30:317-323.
22. Emara AM, Barber NJ. The continuous evolution of the Greenlight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol 2014; 28:73-78.
23. Hueber PA, Liberman D, Ben-Zvi T, et al. 180W vs 120W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: A global, multicenter comparative analysis of perioperative treatment parameters. Urology 2013; 82:1108-1113.
24. West KE, Woo HH. Does prostate size impact upon perioperative outcomes associated with photoselective vaporization of the prostate using the 180W lithium triborate laser? Urol Ann 2015; 7:17-20.
25. Hueber PA, Ben-Zvi T, Liberman D, et al. Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes 100 cc. Can J Urol 2012; 19:6450-6458.
26. Pfitzenmaier J, Gilfrich C, Pritsch M, et al. Vaporization of prostates of > or1/480 mL using a potassium-Titanyl-phosphate laser: midterm-results and comparison with prostates of mL. BJU Int 2008; 102:322-327
27. Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm followup. Eur Urol 2010; 58:349-355.
28. Lebdai S, Prezelin Y, Pereira H, Bruyere F. Prostate-specific antigen evolution afterphotoselectivevaporizationof theprostate. JEndourol2014;28:347-352.
29. Goh AC, Gonzalez RR. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: A cost analysis. J Urol 2010; 183:1469-1473.